[Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy; D006978:Hypertension, Renovascular / Q000175:diagnosis; D007263:Infusions, Parenteral; D009842:Oligopeptides; D011392:Proline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012504:Saralasin / Q000008:administration & dosage / Q000627:therapeutic use; D013722:Teprotide / Q000008:administration & dosage / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D009842:Oligopeptides; D000804:Angiotensin II; D011392:Proline; D013722:Teprotide; D012504:Saralasin
Primenenie spetsificheskikh ingibitorov angiotenzina v diagnostike i lechenii arterial'noĭ gipertonii.